for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

JP Business

AstraZeneca vaccine turns profitable

AstraZeneca's COVID-19 vaccine made a small contribution to earnings in the third quarter and it expects the shot to move to "modest profitability" on new orders after the drugmaker on Friday posted $1.05 billion in vaccine sales for the period. Francis Maguire reports.

JP Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up